Article info

PDF
Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer

Authors

  1. Correspondence to Dr. Ami A Shah, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; Ami.Shah{at}jhmi.edu
View Full Text

Citation

Igusa T, Hummers LK, Visvanathan K, et al
Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer

Publication history

  • Received January 11, 2018
  • Revised March 20, 2018
  • Accepted March 29, 2018
  • First published April 20, 2018.
Online issue publication 
July 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.